ArticleMolecular therapy. Nucleic acids2020

circSETD3 Contributes to Acquired Resistance to Gefitinib in Non-Small-Cell Lung Cancer by Targeting the miR-520h/ABCG2 Pathway.

Yutang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.